Torben Nissen

Torben Nissen

Gründer bei
Flagship Labs 84, Inc.
55 Jahre
Health Technology
Commercial Services
Finance

Profil

Dr. Torben S.
Nissen is a Chairman & Chief Executive Officer at Repertoire Immune Medicines, Inc., a Chairman at Etiome, Inc., an Executive Partner at Flagship Pioneering, Inc. and a Chief Executive Officer, Treasurer & Director at Torque Therapeutics, Inc. He is on the Board of Directors at Torque Therapeutics, Inc. Dr. Nissen was previously employed as an Independent Director by Axcella Health, Inc., a President by VL26, INC., a Head-Worldwide Research & Development by Pfizer Inc., a Chief Operating Officer & Executive Director by Centers for Therapeutic Innovation, a Chief Operating Officer by Ascendis Pharma A/S, a Managing Director by Maxygen, Inc., a President by Moksha8 Pharmaceuticals, Inc., and a Principal by Novo Nordisk A/S.
He also served on the board at Ring Therapeutics, Inc. He received his graduate degree from Technical University of Denmark and a doctorate degree from Technical University of Denmark.

Aktive Positionen von Torben Nissen

UnternehmenPositionBeginn
Private Equity Investor 01.11.2016
Vorstandsvorsitzender 01.01.2024
Gründer 01.01.2021
Vorstandsvorsitzender -

Ehemalige bekannte Positionen von Torben Nissen

UnternehmenPositionEnde
AXCA HEALPAR Direktor/Vorstandsmitglied 01.11.2023
Direktor/Vorstandsmitglied 01.12.2021
RUBIUS THERAPEUTICS Präsident 24.07.2019
PFIZER INC. Corporate Officer/Principal 01.11.2016
Centers for Therapeutic Innovation
Geschäftsführer 01.01.2014
Sehen Sie sich die Erfahrung von Torben Nissen im Detail an

Ausbildung von Torben Nissen

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

80

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Centers for Therapeutic Innovation

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Torben Nissen